Table 1.
Characteristics of the patients.
| EAC | GAC | SBAC | LBAC | PDAC | BDAC | |
|---|---|---|---|---|---|---|
| n (total) | 685 | 582 | 11 | 319 | 316 | 52 |
| n (MSI-H) | 8 (1.4%) | 44 (8.3%) | 2 (18.2%) | 27 (8.5%) | 0 (0%) | 1 (1.9%) |
| UICC Stage | ||||||
| 1 | 144 | 90 | 1 | 49 | 18 | 10 |
| 2 | 166 | 110 | 1 | 78 | 118 | 14 |
| 3 | 289 | 127 | 5 | 34 | 8 | 4 |
| 4 | 78 | 63 | 4 | 79 | 15 | 24 |
| not available | 8 | 138 | 0 | 79 | 0 | 0 |
| Gender | ||||||
| female | 85 | 166 | 3 | 120 | 146 | 21 |
| male | 600 | 327 | 8 | 199 | 170 | 31 |
| not available | 0 | 35 | 0 | 0 | 0 | 0 |
| Age | ||||||
| >60 | 349 | 132 | 4 | 250 | 236 | 13 |
| <60 | 305 | 286 | 6 | 69 | 78 | 39 |
| not available | 31 | 110 | 1 | 0 | 0 | 0 |
Compilation of all examined patients and the tumor characteristics (UICC tumor stages, gender and age distribution). EAC, esophageal adenocarcinoma; GAC, gastric adenocarcinoma; SBAC, small bowel adenocarcinoma; LBAC, large bowel adenocarcinoma; PDAC, pancreatic ductal adenocarcinoma; BDAC, bile duct adenocarcinoma.